Tramadol can reduce nerve pain, but it’s not the strongest option available. In clinical trials, about 53% of people taking tramadol for nerve pain achieved at least 50% pain relief, compared to 30% on placebo. That translates to a number needed to treat (NNT) of 4.4, meaning roughly one in every four or five people who try it will get meaningful relief they wouldn’t have gotten otherwise. Those numbers put tramadol in a middle tier: better than placebo, but not as consistently effective as first-line nerve pain medications.
Why Tramadol Works Differently Than Other Painkillers
Most opioid painkillers work in one way: they bind to opioid receptors in the brain and spinal cord to dampen pain signals. Tramadol does this too, but weakly. What makes it more relevant for nerve pain is its second mechanism. It also increases levels of two chemical messengers, serotonin and norepinephrine, by preventing the body from reabsorbing them. These same messengers are targeted by antidepressants that are commonly prescribed for nerve pain, which is why tramadol has a foot in both worlds.
This dual action is the reason tramadol gets considered for nerve pain at all. Pure opioids tend to be less effective for nerve pain than for other types of pain like post-surgical or injury-related pain. The added serotonin and norepinephrine activity gives tramadol a mechanism that more directly addresses the way damaged nerves misfire.
Where Tramadol Ranks in Treatment Guidelines
International pain management guidelines have recently downgraded tramadol. It was previously classified as a second-line treatment for nerve pain, but updated recommendations published in The Lancet Neurology now group it with opioids as a third-line option with a weak recommendation. In practical terms, this means doctors are advised to try other medications first.
First-line treatments for nerve pain include certain antidepressants (tricyclics and SNRIs) and medications originally developed for seizures that calm overactive nerves. These have stronger and more consistent evidence behind them. Second-line options include topical treatments like high-concentration capsaicin patches and lidocaine plasters. Tramadol sits behind all of these, typically reserved for people who haven’t responded to or can’t tolerate the preferred medications.
How Quickly It Works
Standard tramadol tablets and drops begin working within 30 to 60 minutes. Slow-release formulations, which deliver the medication over 12 or 24 hours, take longer to kick in but provide steadier relief throughout the day. For chronic nerve pain, slow-release versions are more commonly used because nerve pain tends to be persistent rather than coming in isolated flares.
Keep in mind that the clinical trials measuring tramadol’s effectiveness for nerve pain ran over weeks, not hours. While you may notice some immediate pain reduction, the full picture of whether tramadol is working for your nerve pain typically becomes clearer after consistent use over several weeks.
Risks That Matter
Tramadol carries a specific set of risks that go beyond what you’d expect from a standard painkiller. The most important one involves its interaction with other medications that raise serotonin levels. If you take an antidepressant (particularly an SSRI or SNRI), St. John’s wort, or lithium, combining it with tramadol creates a high risk of serotonin syndrome. This is a rare but potentially life-threatening reaction where excess serotonin causes agitation, rapid heart rate, high blood pressure, and in severe cases, seizures or loss of consciousness.
This interaction is especially relevant for people with nerve pain because many of them are already taking antidepressants, either for mood or as a first-line nerve pain treatment. That overlap can make tramadol a poor fit even when it might otherwise help.
Tramadol can also lower the seizure threshold, meaning it makes seizures more likely in people who are already vulnerable. It carries the same dependence risk as other opioids, though the risk is generally considered lower than with stronger opioids.
Extra Caution for Older Adults
The American Academy of Family Physicians specifically warns against prescribing tramadol to older adults without carefully weighing the risks. Sedation and dizziness increase the chance of falls and fractures. Tramadol can also cause low blood sugar and low sodium levels, both of which are particularly dangerous in older people and can themselves trigger falls, confusion, or seizures.
People with reduced kidney function face heightened risk because the body clears tramadol more slowly, allowing it to build up to higher levels. There’s also significant genetic variability in how people metabolize tramadol. The enzyme responsible for converting it into its active form varies widely from person to person, which means some people get very little pain relief while others experience unexpectedly strong effects from the same dose.
How It Compares to First-Line Options
The medications recommended before tramadol generally offer better evidence and fewer concerns about dependence. Tricyclic antidepressants and SNRIs work on the same serotonin and norepinephrine pathways that give tramadol part of its effectiveness, but they do so without opioid activity. Nerve-calming medications originally designed for epilepsy take a different approach, reducing the abnormal electrical signaling that damaged nerves produce.
Tramadol’s NNT of 4.4 is reasonable but not exceptional. It means that for every four to five people who try it, one will experience significant relief attributable to the drug rather than placebo. For context, the best first-line nerve pain medications tend to have NNTs in a similar or slightly better range, but with stronger overall evidence from larger studies. The Cochrane review on tramadol for nerve pain noted that data was limited, with only three studies (265 participants) reporting on significant pain reduction.
Where tramadol sometimes finds a practical role is as a bridge: providing faster-acting relief in the weeks it takes for first-line medications to reach full effectiveness, or as an addition when first-line treatments help but don’t fully control the pain. It can also be an option for people who can’t tolerate the side effects of first-line drugs, which commonly include weight gain, drowsiness, and dizziness of their own.